BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8380592)

  • 1. Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line.
    Chan VT; Ng SW; Eder JP; Schnipper LE
    J Biol Chem; 1993 Jan; 268(3):2160-5. PubMed ID: 8380592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line.
    Sullivan DM; Latham MD; Rowe TC; Ross WE
    Biochemistry; 1989 Jun; 28(13):5680-7. PubMed ID: 2550059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids.
    Glisson BS; Killary AM; Merta P; Ross WE; Siciliano J; Siciliano MJ
    Cancer Chemother Pharmacol; 1992; 31(2):131-8. PubMed ID: 1333369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents.
    Hashimoto S; Danks MK; Chatterjee S; Beck WT; Berger NA
    Oncol Res; 1995; 7(1):21-9. PubMed ID: 7549041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance.
    Tanizawa A; Beitrand R; Kohlhagen G; Tabuchi A; Jenkins J; Pommier Y
    J Biol Chem; 1993 Dec; 268(34):25463-8. PubMed ID: 8244980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomerase.
    Glisson BS; Sullivan DM; Gupta R; Ross WE
    NCI Monogr; 1987; (4):89-93. PubMed ID: 2819738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    Bugg BY; Danks MK; Beck WT; Suttle DP
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
    Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of multiple copies of a mutant topoisomerase IIalpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines.
    Campain JA; Slovak ML; Schoenlein PV; Popescu NC; Gottesman MM; Pastan I
    Somat Cell Mol Genet; 1995 Nov; 21(6):451-71. PubMed ID: 8600572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.
    Glisson B; Gupta R; Smallwood-Kentro S; Ross W
    Cancer Res; 1986 Apr; 46(4 Pt 2):1934-8. PubMed ID: 3004711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
    Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
    Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
    Yu Q; Mirski SE; Sparks KE; Cole SP
    Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells.
    Eder JP; Chan VT; Niemierko E; Teicher BA; Schnipper LE
    J Biol Chem; 1993 Jul; 268(19):13844-9. PubMed ID: 8390979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
    Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
    Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.
    Danks MK; Warmoth MR; Friche E; Granzen B; Bugg BY; Harker WG; Zwelling LA; Futscher BW; Suttle DP; Beck WT
    Cancer Res; 1993 Mar; 53(6):1373-9. PubMed ID: 8383009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429.
    Campain JA; Gottesman MM; Pastan I
    Biochemistry; 1994 Sep; 33(37):11327-32. PubMed ID: 7727383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II.
    Deffie AM; McPherson JP; Gupta RS; Hedley DW; Goldenberg GJ
    Biochem Cell Biol; 1992 May; 70(5):354-64. PubMed ID: 1353968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.
    Hasinoff BB; Kuschak TI; Creighton AM; Fattman CL; Allan WP; Thampatty P; Yalowich JC
    Biochem Pharmacol; 1997 Jun; 53(12):1843-53. PubMed ID: 9256159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development.
    Tsutsui K; Tsutsui K; Okada S; Watanabe M; Shohmori T; Seki S; Inoue Y
    J Biol Chem; 1993 Sep; 268(25):19076-83. PubMed ID: 8395528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.